{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:43:10Z","timestamp":1778618590491,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00520-017-4004-1","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T08:11:15Z","timestamp":1513843875000},"page":"1841-1849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4338-1961","authenticated-orcid":false,"given":"S.","family":"Carnio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Galetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. L.","family":"Cortinovis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Antonuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Pisconti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. L.","family":"Cecere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lunghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Del Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. S.","family":"Montagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Topulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Pelizzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. G.","family":"Rapetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gianetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. V.","family":"Pacchiana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Cataldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Novello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"4004_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.critrevonc.2015.12.001","volume":"99","author":"S Sommariva","year":"2016","unstructured":"Sommariva S, Pongiglione B, Tarricone R (2016) Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: a systematic review. Crit Rev Oncol Hematol 99:13\u201336. \n                    https:\/\/doi.org\/10.1016\/j.critrevonc.2015.12.001","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"4004_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/annonc\/mdh110","volume":"15","author":"A Ihbe-Heffinger","year":"2004","unstructured":"Ihbe-Heffinger A, Ehlken B, Bernard R, Berger K, Peschel C, Eichler HG, Deuson R, Th\u00f6dtmann J, Lordick F (2004) The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers. Ann Oncol 15(3):526\u2013536. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdh110","journal-title":"Ann Oncol"},{"issue":"10","key":"4004_CR3","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cncr.20230","volume":"100","author":"SM Grunberg","year":"2004","unstructured":"Grunberg SM, Deuson RR, Mavros P, Geling O, Hansen M, Cruciani G, Daniele B, de Pouvourville G, Rubenstein EB, Daugaard G (2004) Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer 100(10):2261\u20132268. \n                    https:\/\/doi.org\/10.1002\/cncr.20230","journal-title":"Cancer"},{"key":"4004_CR4","unstructured":"MASSC\/ESMO. MASSC (2016) [Online] [Cited: July 27, 2016] \n                    http:\/\/www.mascc.org\/antiemetic-guidelines"},{"key":"4004_CR5","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2147\/TCRM.S89215","volume":"12","author":"V Lorusso","year":"2016","unstructured":"Lorusso V (2016) Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant\/palonosetron. Ther Clin Risk Manag 12:917\u2013925. \n                    https:\/\/doi.org\/10.2147\/TCRM.S89215","journal-title":"Ther Clin Risk Manag"},{"issue":"5","key":"4004_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jpainsymman.2013.06.012","volume":"47","author":"A Molassiotis","year":"2014","unstructured":"Molassiotis A, Aapro M, Dicato M, Gascon P, Novoa SA, Isambert N, Burke TA, Gu A, Roila F (2014) Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study. J Pain Symptom Manag 47(5):839\u2013848. \n                    https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.06.012","journal-title":"J Pain Symptom Manag"},{"issue":"31","key":"4004_CR7","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1200\/JCO.2010.34.4614","volume":"29","author":"E Basch","year":"2011","unstructured":"Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, Chesney M, Clark-Snow RA, Flaherty AM, Freundlich B, Morrow G, Rao KV, Schwartz RN, Lyman GH, American Society of Clinical Oncology (2011) American Society of Clinical OncologyAntiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29(31):4189\u20134198. \n                    https:\/\/doi.org\/10.1200\/JCO.2010.34.4614","journal-title":"J Clin Oncol"},{"issue":"1","key":"4004_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33(1):159\u2013174. \n                    https:\/\/doi.org\/10.2307\/2529310","journal-title":"Biometrics"},{"issue":"5","key":"4004_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00520-006-0173-z","volume":"15","author":"L Cohen","year":"2007","unstructured":"Cohen L, de Moor CA, Eisenberg P, Ming EE, Hu H (2007) Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings. Support Care Cancer 15(5):497\u2013503. \n                    https:\/\/doi.org\/10.1007\/s00520-006-0173-z","journal-title":"Support Care Cancer"},{"issue":"8","key":"4004_CR10","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","volume":"33","author":"M Maio Di","year":"2015","unstructured":"Di Maio M, Gallo C, Leighl NB, Piccirillo MC, Daniele G, Nuzzo F, Gridelli C, Gebbia V, Ciardiello F, de Placido S, Ceribelli A, Favaretto AG, de Matteis A, Feld R, Butts C, Bryce J, Signoriello S, Morabito A, Rocco G, Perrone F (2015) Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol 33(8):910\u2013915. \n                    https:\/\/doi.org\/10.1200\/JCO.2014.57.9334","journal-title":"J Clin Oncol"},{"issue":"11","key":"4004_CR11","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1007\/s00520-015-2750-5","volume":"23","author":"C Vidall","year":"2015","unstructured":"Vidall C, Fern\u00e1ndez-Ortega P, Cortinovis D, Jahn P, Amlani B, Scott\u00e9 F (2015) Impact and management of chemotherapy\/radiotherapy-induced nausea and vomiting and the perceptual gap between oncologists\/oncology nurses and patients: a cross-sectional multinational survey. Support Care Cancer 23(11):3297\u20133305. \n                    https:\/\/doi.org\/10.1007\/s00520-015-2750-5","journal-title":"Support Care Cancer"},{"issue":"6","key":"4004_CR12","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jpainsymman.2015.12.317","volume":"51","author":"A Molassiotis","year":"2016","unstructured":"Molassiotis A, Lee PH, Burke TA, Dicato M, Gascon P, Roila F, Aapro M (2016) Anticipatory nausea, risk factors, and its impact on chemotherapy-induced nausea and vomiting: results from the Pan European Emesis Registry study. J Pain Symptom Manag 51(6):987\u2013993. \n                    https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.12.317","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"4004_CR13","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00520-015-3000-6","volume":"24","author":"R Chow","year":"2016","unstructured":"Chow R, Chiu L, Navari R, Passik S, Chiu N, Popovic M, Lam H, Pasetka M, Chow E, DeAngelis C (2016) Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review. Support Care Cancer 24(2):1001\u20131008. \n                    https:\/\/doi.org\/10.1007\/s00520-015-3000-6","journal-title":"Support Care Cancer"},{"issue":"1","key":"4004_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00520-016-3386-9","volume":"25","author":"S Mukhopadhyay","year":"2017","unstructured":"Mukhopadhyay S, Kwatra G, Alice KP, Badyal D (2017) Role of olanzapine in chemotherapy-induced nausea and vomiting on platinum-based chemotherapy patients: a randomized controlled study. Support Care Cancer 25(1):145\u2013154. \n                    https:\/\/doi.org\/10.1007\/s00520-016-3386-9","journal-title":"Support Care Cancer"},{"issue":"1","key":"4004_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00520-014-2376-z","volume":"23","author":"HK Kim","year":"2015","unstructured":"Kim HK, Hsieh R, Chan A et al (2015) Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice. Support Care Cancer 23(1):293\u2013300. \n                    https:\/\/doi.org\/10.1007\/s00520-014-2376-z","journal-title":"Support Care Cancer"},{"issue":"1","key":"4004_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00520-014-2339-4","volume":"23","author":"T Kitazaki","year":"2015","unstructured":"Kitazaki T, Fukuda Y, Fukahori S, Oyanagi K, Soda H, Nakamura Y, Kohno S (2015) Usefulness of antiemetic therapy with aprepitant, palonosetron, and dexamethasone for lung cancer patients on cisplatin-based or carboplatin-based chemotherapy. Support Care Cancer 23(1):185\u2013190. \n                    https:\/\/doi.org\/10.1007\/s00520-014-2339-4","journal-title":"Support Care Cancer"},{"issue":"2","key":"4004_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11912-017-0571-z","volume":"19","author":"AM Stover","year":"2017","unstructured":"Stover AM, Basch EM (2017) The potential role of symptom questionnaires in palliative and supportive cancer care delivery. Curr Oncol Rep 19(2):12. \n                    https:\/\/doi.org\/10.1007\/s11912-017-0571-z","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"4004_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1740774517698645","volume":"14","author":"TR Mendoza","year":"2017","unstructured":"Mendoza TR, Dueck AC, Bennett AV, Mitchell SA, Reeve BB, Atkinson TM, Li Y, Castro KM, Denicoff A, Rogak LJ, Piekarz RL, Cleeland CS, Sloan JA, Schrag D, Basch E (2017) Evaluation of different recall periods for the US National Cancer Institute\u2019s PRO-CTCAE. Clin Trials 14(3):255\u2013263. \n                    https:\/\/doi.org\/10.1177\/1740774517698645","journal-title":"Clin Trials"},{"issue":"2","key":"4004_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jama.2017.7156","volume":"318","author":"E Basch","year":"2017","unstructured":"Basch E, Deal AM, Dueck AC et al (2017) Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA 318(2):197\u2013198","journal-title":"JAMA"},{"issue":"2","key":"4004_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMp1611252","volume":"376","author":"E Basch","year":"2017","unstructured":"Basch E (2017) Patient-reported outcomes\u2014harnessing patients\u2019 voices to improve clinical care. N Engl J Med 376(2):105\u2013108","journal-title":"N Engl J Med"},{"issue":"1","key":"4004_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/AAP.0b013e31823ebc74","volume":"37","author":"Y Ma","year":"2012","unstructured":"Ma Y, Mazumdar M, Memtsoudis SG (2012) Beyond repeated measures ANOVA: advanced statistical methods for the analysis of longitudinal data in anesthesia research. Reg Anesth Pain Med 37(1):99\u2013105. \n                    https:\/\/doi.org\/10.1097\/AAP.0b013e31823ebc74","journal-title":"Reg Anesth Pain Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-4004-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-4004-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-4004-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:10:28Z","timestamp":1568718628000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-4004-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4004"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-4004-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]},"assertion":[{"value":"9 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SN has been a speaker bureau for Eli Lilly, Roche, Merck Sharp & Dohme, Bristol Myers Squibb, Boehringer Ingelheim, and Astra Zeneca. VP and NC are Quintiles IMS employees. All remaining authors have declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}